T-Cell and NK-Cell Lymphomas From Biology to Novel Therapies 1st Editon 2018 Hardbound at Meripustak

T-Cell and NK-Cell Lymphomas From Biology to Novel Therapies 1st Editon 2018 Hardbound

Books from same Author: Christiane Querfeld, Jasmine Zain, Steven T. Rosen

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 16235/- [ 5.00% off ]

    Seller Price: ₹ 15423

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Christiane Querfeld, Jasmine Zain, Steven T. Rosen
    PublisherSpringer
    Edition1st Edition
    ISBN9783319997155
    Pages287
    BindingHardbound
    LanguageEnglish
    Publish YearDecember 2018

    Description

    Springer T-Cell and NK-Cell Lymphomas From Biology to Novel Therapies 1st Editon 2018 Hardbound by Christiane Querfeld, Jasmine Zain, Steven T. Rosen

    In this book, a group of internationally distinguished lymphoma experts provide a comprehensive review of the most important advances in the biology, diagnosis, and therapy of T cell and NK cell malignancies. In particular, it demonstrates in detail how advances in our understanding of the tumor microenvironment and molecular biology have helped to elucidate the pathogenesis of these lymphomas, improve diagnostic and prognostic accuracy, and develop novel therapies that promise improved patient outcomes. Individual chapters are devoted to particular tumor types and subtypes, and all aspects of transplantation for patients with T cell and NK cell lymphomas are discussed. As such, the book offers a valuable resource for hematologists, oncologists, hematopathologists, and all those seeking an up-to-date overview of how new, targeted therapies are delivering better disease control and improved quality of life. Epidemiology and Pathology of T cell lymphomas/NK cell lymphomas.- Molecular and genomic landscape.- Microenvironment.- PTCL, NOS.- AITL .- ALCL.- Adult T cell leukemia/lymphoma.- NK Cell lymphomas.- Hepatosplenic T cell lymphoma.- Rare subtypes e.g. gamma-delta T cell lymphoma.- Mycosis fungoides/Sézary syndrome.- CD30+ Lymphoproliferative disorders.- Transplantation.